A nuclear heart scan is utilized to assess coronary blood flow, to evaluate the presence of damaged cardiac muscle and to evaluate left ventricular function.
Images are taken after a stress test and when the heart recovers to a restful status.
Utilize a radionuclide such as thallium 201 or technetium 99m-labeled sestamibi which are detected by nuclear imaging.
Often prepared by commercial nuclear pharmacies and distributed to hospitals and clinics.
There are two main types of nuclear heart scanning, a single positron emission computed tomography (SPECT) and cardiac positron emission tomography (PET).
SPECT is the most well-established and widely used type, while PET is newer.
SPECT is the most common nuclear cardiac scanning test for diagnosing coronary heart disease.
The most commonly used tracers are thallium-201, technetium-99m sestamibi (Cardiolite), and technetium-99m tetrofosmin (Myoview).
A resting scan combined with a stress scan using the radioactive tracer technetium-99m sestamibi – averages 11.3 mSv. exposure,, about 500 times the dose that comes from a chest x-ray.
A rest-stress scan using the radioactive tracer technetium-99m tetrofosmin averages 9.3 mSv. !about 500 times the dose that comes from a chest x-ray.
Doses are much higher for nuclear stress tests that use the radioactive tracer thallium-201 – about 22 mSv with a single injection of thallium.
When thallium and technetium-99m sestamibi are combined, the radiation dose averages about 29.2 mSv.
PET nuclear cardiac scans provide more detailed pictures of the heart.
No clear cut advantage of using SPECT over PET scans exists.
PET takes a clearer picture through thick layers of tissues of the chest wall and is better than SPECT at showing whether coronary heart disease is affecting more than one coronary artery.
If a SPECT scan does not provide adequate information a PET nuclear heart scan can be considered